Lipids as risk factors for stroke and CHD

DeFilippis, Andrew; Bhatia, Rinky; Jones, Steven
July 2009
Cardiology Today;Jul2009, Vol. 12 Issue 7, p4
The article focuses on low density lipoprotein (LDL) as one of the risk factors for coronary heart disease (CHD).


Related Articles

  • Non-HDL vs. LDL: Which Carries the Greater Risk? Orringer, Carl E. // Cardiology Today;Feb2012 Practical Lipidology, p11 

    The article examines the clinical utility of non-low-density lipoprotein cholesterol (HDL-C) in assessing coronary heart disease (CHD) risk by defining its calculation and reviewing studies of its superiority relative to serum triglycerides and LDL-C as a CHD risk predictor and goal for therapy.

  • The Medical Roundtable - CV Edition Spring 2011. Moser, Marvin // Medical Roundtable: Cardiovascular Edition;Spring2011, Vol. 2 Issue 2, p68 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the use of statins and other agents which lower low-density lipoproteins (LDL) choles­terol, the risk of residual coronary heart disease, and the use of spironolactone.

  • Homocysteine in Angiographically Proven Coronary Disease. Halilovic, Enes; Kabil, Emir; Ljuca, Farid; Nuhbegovic, Sabina // Medicinski Arhiv;2009, Vol. 63 Issue 5, p256 

    The research included 200 subjects, of which 150 had angiographically proven coronary disease with the coronary artery stenosis of 50% or more, and 50 subjects who did not have angiographically proven coronary disease. Patients were chosen randomly out of approximately 1000 patients who...

  • Heartsick America. Cowley, Geoffrey // Bulletin with Newsweek;05/29/2001, Vol. 119 Issue 6276, p96 

    Reports on the National Heart, Lung & Blood Institute study on the effect of lowering high blood cholesterol levels on the risk of coronary heart disease. Low density lipoprotein (LDL) limits recommended for different groups of people; Usefulness of drugs in preventing heart attacks by lowering...

  • A novel LDLR mutation, H190Y, in a Utah kindred with familial Hypercholesterolemia. Hopkins, Paul N.; Wu, Lily L.; Stephenson, Susan H.; Xin, Yuanpei; Katsumata, Harumi; Nobe, Yukiko; Nakajima, Toshiaki; Hirayama, Tsunenori; Emi, Mitsuru; Williams, Roger R. // Journal of Human Genetics;1999, Vol. 44 Issue 6, p364 

    Abstract Heterozygous familial hypercholesterolemia (FH) is a serious disorder causing twice normal low-density lipoprotein (LDL) cholesterol levels early in childhood and very early coronary disease in both men and women. Treatment with multiple medications together with diet can normalize...

  • Positive exercise test a bad omen even for men without usual CHD risks.  // Modern Medicine;May98, Vol. 66 Issue 5, p24 

    Reveals that men with no conventional risk factors for coronary heart disease (CHD) who have a positive exercise test still have a higher risk of death from CHD according to Doctor Ming Wei. Examples of conventional risk factors; Beneficial effect of low-density lipoprotein (LDL) reduction therapy.

  • C-reactive protein: From acute phase reactant to cardiovascular disease risk factor. Woodhouse, Sherry // MLO: Medical Laboratory Observer;Mar2002, Vol. 34 Issue 3, p12 

    Discusses the role of low-density lipoproteins and their oxidative modification through the inflammatory process in antherogenesis. Definition of coronary heart diseas risk; Information on lipids; Effects of atherosclerosis; Detail of plaque rupture and instability. INSETS: Coronary heart...

  • The size of LDL appears to be tied to the risk of MI, but not everyone agrees on its clinical value.  // Modern Medicine;Nov96, Vol. 64 Issue 11, p14 

    Reports that small, dense low density lipoproteins (LDL) cholesterol can predict an individual's risk for developing coronary artery disease (CAD), based on a study by Christopher D. Gardner et al. Case studies; CAD risk factors; Recommendations; Publication of the study findings in the...

  • LIPID MANAGEMENT.  // Monthly Prescribing Reference;Jan2014, Vol. 30 Issue 1, p20 

    The article focuses on low-density lipoprotein-cholesterol (LDL-C) as the main goal of lipid management. Topics include Therapeutic Lifestyle Changes (TLC) as the first-line therapy and reserve drug therapy for higher risk patients, doing lipoprotein analysis for in case of coronary heart...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics